Medtronic begins pacemaker trials
This article was originally published in Clinica
Executive Summary
Medtronic has begun European trials of its new Kappa 400 pacemaker. Dual-chamber devices have been implanted in patients in Italy and Denmark. A single-chamber version will also be evaluated in the 50-patient trial. Medtronic spokesman Dick Reid says data from a separate trial of a similar but larger device will be used for seeking regulatory approvals, although the larger pacemaker will probably not be marketed.